X-23671559-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_006406.2(PRDX4):āc.272C>Gā(p.Thr91Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000713 in 1,205,532 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 32 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000036 ( 0 hom., 2 hem., cov: 23)
Exomes š: 0.000075 ( 0 hom. 30 hem. )
Consequence
PRDX4
NM_006406.2 missense
NM_006406.2 missense
Scores
4
8
5
Clinical Significance
Conservation
PhyloP100: 7.57
Genes affected
PRDX4 (HGNC:17169): (peroxiredoxin 4) The protein encoded by this gene is an antioxidant enzyme and belongs to the peroxiredoxin family. The protein is localized to the cytoplasm. Peroxidases of the peroxiredoxin family reduce hydrogen peroxide and alkyl hydroperoxides to water and alcohol with the use of reducing equivalents derived from thiol-containing donor molecules. This protein has been found to play a regulatory role in the activation of the transcription factor NF-kappaB. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Hemizygotes in GnomAd4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRDX4 | NM_006406.2 | c.272C>G | p.Thr91Arg | missense_variant | 2/7 | ENST00000379341.9 | NP_006397.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRDX4 | ENST00000379341.9 | c.272C>G | p.Thr91Arg | missense_variant | 2/7 | 1 | NM_006406.2 | ENSP00000368646.4 | ||
PRDX4 | ENST00000379331.3 | c.272C>G | p.Thr91Arg | missense_variant | 2/3 | 2 | ENSP00000368635.3 | |||
PRDX4 | ENST00000379349.5 | c.230C>G | p.Thr77Arg | missense_variant | 2/4 | 3 | ENSP00000368654.1 | |||
PRDX4 | ENST00000495599.1 | n.384C>G | non_coding_transcript_exon_variant | 3/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000357 AC: 4AN: 112001Hom.: 0 Cov.: 23 AF XY: 0.0000585 AC XY: 2AN XY: 34177
GnomAD3 genomes
AF:
AC:
4
AN:
112001
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
34177
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000284 AC: 5AN: 176261Hom.: 0 AF XY: 0.0000490 AC XY: 3AN XY: 61211
GnomAD3 exomes
AF:
AC:
5
AN:
176261
Hom.:
AF XY:
AC XY:
3
AN XY:
61211
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000750 AC: 82AN: 1093531Hom.: 0 Cov.: 29 AF XY: 0.0000835 AC XY: 30AN XY: 359405
GnomAD4 exome
AF:
AC:
82
AN:
1093531
Hom.:
Cov.:
29
AF XY:
AC XY:
30
AN XY:
359405
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000357 AC: 4AN: 112001Hom.: 0 Cov.: 23 AF XY: 0.0000585 AC XY: 2AN XY: 34177
GnomAD4 genome
AF:
AC:
4
AN:
112001
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
34177
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
5
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2023 | The c.272C>G (p.T91R) alteration is located in exon 2 (coding exon 2) of the PRDX4 gene. This alteration results from a C to G substitution at nucleotide position 272, causing the threonine (T) at amino acid position 91 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T;T
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Benign
T
MutationAssessor
Benign
.;M;.
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D
REVEL
Uncertain
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
0.99
.;D;.
Vest4
0.82, 0.87
MutPred
0.38
.;Loss of phosphorylation at Y87 (P = 0.2722);Loss of phosphorylation at Y87 (P = 0.2722);
MVP
MPC
1.9
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at